NCT03392168 - Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions

Psoriasis

Interventions

DRUG

ARQ-151 cream 0.5%

0.5% active concentration

DRUG

ARQ-151 cream 0.15%

0.15% active concentration

DRUG

ARQ-151 vehicle cream

Vehicle cream

Trial Locations (8)

Mosaic Dermatology, Santa Monica

Dr. Chih-ho Hong Medical Inc., Surrey

Lynderm Research Inc., Markham

Research by ICLS, Oakville

SKiN Centre for Dermatology, Peterborough

The Centre for Dermatology, Richmond Hill

K. Papp Clinical Research Inc., Waterloo

XLR8 Medical Research Inc., Windsor